$195,000 Awarded in Childhood Cancer Research Grants to the University of Colorado

DENVER (September 16, 2014) – The St. Baldrick’s Foundation, a volunteer-driven and donor-centered charity dedicated…

Read the rest of this entry

Collaboration Between CU Cancer Center and NantBioScience Targets Ral Protein

Collaboration between CU Cancer Center and NantBioScience will allow Theodorescu and team to work toward drugs that target Ral protein activation, implicated in nearly a third of all cancers.

Read the rest of this entry

Wings of Hope to benefit pancreatic cancer research at CU Cancer Center

Of all major cancers including breast, prostate, and lung, pancreatic cancer has the highest mortality…

Read the rest of this entry

CU Cancer Center receives $2.7M

Earlier this month the Morton and Sandra Saffer Cancer Center Fund generously donated $2.7M to…

Read the rest of this entry

A Teal Saturday: Gynecologic Cancer Symposium at CU

Dressed in teal and enjoying breakfast and visionary talks from leading women’s cancer researchers, 65…

Read the rest of this entry

New Knowledge of Genes Driving Bladder Cancer Points to Targeted Treatments

A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward defining the genetics of bladder cancer, and implies there may be at least two distinct genetic types of the disease.

Read the rest of this entry

Dan Theodorescu, Director of CU Cancer Center, Joins Health Care Thought Leaders in DC

AURORA, Colo – On September 10, at the invitation of Rep. Diana DeGette (D)  and…

Read the rest of this entry

Pierce Brosnan Announces New Stand Up To Cancer Dream Team Dedicated to Ovarian Cancer

Stand Up To Cancer, Pierce Brosnan and Colorado’s HERA Women’s Cancer Foundation announce new Dream Team to fight ovarian cancer.

Read the rest of this entry

Panel: Time is now for U.S. to lead in biomedical research

The United States is in danger of losing its biomedical edge to countries that are…

Read the rest of this entry

Allen Lichter, CEO of ASCO, Says Big Data, Cost/Value and “-Omics” Will Dominate Oncology in 2030

At the CU Cancer Center Fall Retreat 2014, Allen S. Lichter, MD, FASCO, CEO of ASCO, points the way toward the future of oncology in 2030

Read the rest of this entry